Evidence map›Paper›PMID 37060091›Full record

ArticleJournal of pharmaceutical health care and sciences2023

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience.

Shinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Daisuke Tsutsumi, Takashi Yamauchi, Yoshihiro Hatta, Susumu Ootsuka

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shinya TsuboiDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Tatsuya HayamaDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Katsuhiro MiuraTumor Center, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan. miura.katsuhiro@nihon-u.ac.jp.ORCID http://orcid.org/0000-0002-1538-3804
Akihiro UchiikeDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Daisuke TsutsumiDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Takashi YamauchiDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Yoshihiro HattaDepartment of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Susumu OotsukaDepartment of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
Nihon University Itabashi Hospital · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37060091
PMCPMC10103500
OpenAlexW4365517023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.